Speaker Profile

M.D., Chief Medical Officer, Chief Quality Officer, Baylor Genetics

Biography
Dr. Christine Eng serves as the Chief Medical Officer and Chief Quality Officer at Baylor Genetics. In addition to her role at Baylor Genetics, Dr. Eng is a Professor at Baylor College of Medicine in Houston, TX, as well as a pediatrician, and medical geneticist. As a winner of the 2024 Modern Healthcare Women Leaders in Healthcare award, Dr. Eng is recognized for several contributions to the implementation of genomics in clinical practice. She serves as principal investigator of the genome sequencing core for the National Institutes of Healths Undiagnosed Diseases Network and was elected to the Board of Directors of the American Society of Human Genetics effective January 1, 2024. Dr. Eng received her bachelors degree from Yale University. Following her bachelors, she received her medical degree from Tulane University.


Talk
RNA Sequencing to Help Identify Rare Genetic Disorders
RNA sequencing to help identify and diagnose rare genetic disorders.


Clinical Dx Showcase:
Baylor Genetics

Baylor Genetics provides diagnostic answers to complex medical conditions and rare diseases. The company specializes in rapid Whole Genome Sequencing and Whole Exome Sequencing and complementary panels. Baylor Genetics works to transform healthcare and improve lives by converting scientific innovations into accessible clinical solutions.

 Session Abstract – PMWC 2025 Silicon Valley

Showcase Track S2 - February 5 11.00 A.M.-4.45 P.M.,Showcase Track S2 - February 6 9.15 A.M.-4.45 P.M.,Showcase Track S2 - February 7 11.00 A.M.-1.30 P.M.


The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Neurodegenerative

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by APR. 24TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required